), thought to be integrated into mitochondria via the mitochondrial calcium uniporter (MCU) channel to match energetic demand. Here, we examine a conditional, cardiomyocyte-specific, mutant mouse lacking Mcu, the pore-forming subunit of the MCU channel, in adulthood. Mcu À/À mice display no overt baseline phenotype and are protected against m Ca 2+ overload in an in vivo myocardial ischemia-reperfusion injury model by preventing the activation of the mitochondrial permeability transition pore, decreasing infarct size, and preserving cardiac function. In addition, we find that Mcu À/À mice lack contractile responsiveness to acute b-adrenergic receptor stimulation and in parallel are unable to activate mitochondrial dehydrogenases and display reduced bioenergetic reserve capacity. These results support the hypothesis that MCU may be dispensable for homeostatic cardiac function but required to modulate Ca 2+ -dependent metabolism during acute stress.
although dispensable for homeostatic function, is necessary for the cardiac ''fight-or-flight'' contractile response and a significant contributor to mitochondrial permeability transition during ischemiareperfusion injury.
INTRODUCTION
The cardiomyocyte is unique in that a large and variable flux of intracellular calcium ( i Ca
) must occur to mediate and regulate contraction. Thus, a complex system has evolved to regulate i Ca 2+ transport to maintain homeostatic conditions (Bers, 2008) .
Numerous genetic components have been shown to mediate the passage of i Ca 2+ across the sarcolemma and sarcoplasmic reticulum (SR), and, while great strides have been made toward understanding the temporal and spatial relationship of Ca 2+ in regards to excitation-contraction (EC) coupling, our understanding of other sub-cellular Ca 2+ domains, including the components of mitochondria Ca 2+ ( m Ca   2+ ) exchange, remains elementary.
The dynamic Ca 2+ environment of the heart requires that cardiac mitochondria possess an exchange system capable of dealing with the variable changes in Ca 2+ load. Ca 2+ enters the mitochondrial matrix via the mitochondria calcium uniporter (MCU). The MCU is an inward rectifying, low-affinity, highcapacity channel whose uptake is mediated by mitochondrial membrane potential (Dc = approximately -180 mV) generated by the electron transport chain (ETC) (Kirichok et al., 2004) . The recent identification of the gene encoding the channelforming portion of the uniporter, formerly named CCDC109A now known as MCU, has opened the field to genetic gainand loss-of-function studies to determine experimentally the true role of m Ca 2+ signaling in the regulation of numerous proposed cellular processes (Baughman et al., 2011; De Stefani et al., 2011) . To date, multiple reports have confirmed MCU as being required for acute m Ca 2+ influx into the matrix. However, numerous outstanding questions remain in regards to the molecular regulation of the MCU and the physiological function of m Ca
2+
, particularly in excitable cells such as cardiomyocytes.
The high metabolic demand of contractility makes it essential that an efficient and tightly controlled system be in place to regulate energy production. Oxidative Phosphorylation (OxPhos) is the largest contributor to myocardial metabolism and as such the mitochondria represents a central control point to ensure that energy demands are met. Simultaneous measurements of m Ca 2+ and NADH have correlated increased m Ca 2+ load with increased oxidative phosphorylation and ATP production (Brandes and Bers, 2002; Unitt et al., 1989) . Thus, Ca 2+ is proposed to be the link between EC coupling (ECC) and OxPhos and has been shown to modulate mitochondrial metabolism through numerous mechanisms including the activation of Ca 2+ -dependent dehydrogenases and modulation of ETC complexes (Glancy and Balaban, 2012) . In contrast to the aforementioned pro-survival metabolic signaling, numerous studies have implicated m Ca 2+ overload in the activation of apoptosis and necrosis (Rasola and Bernardi, 2011) . m Ca 2+ is known to cause outer-mitochondrial membrane (OMM) permeability prompting the release of apoptogens. Ca
is also thought to be the major priming event in the opening of the mitochondrial permeability transition pore (MPTP) causing the collapse of Dc and loss of ATP production resulting in necrotic cell death. This mechanism of cellular demise is believed to significantly contribute to the initiation and progression of myocardial infarction and heart failure (Foo et al., 2005) . In addition, it has been speculated that mitochondria in close contact to the sarcoplasmic reticulum (SR) may buffer i Ca 2+ cycling and thereby play a direct role in modulating EC coupling, providing yet another layer of potential regulation (Drago et al., 2012; Rizzuto et al., 1998) . To begin to unravel how m Ca 2+ signaling modulates in vivo physiology, a group at the NHLBI recently generated a Mcu gene-trap mouse (Pan et al., 2013) . As expected, mitochondria isolated from this global Mcu-null mouse failed to take up Ca
. However, while they did find alterations in some aspects of skeletal muscle work capacity, they did not find a significant cardiac phenotype. Particularly intriguing, they found no change in myocardial infarct size in an ex vivo global ischemia model even though in vitro indices of MPTP opening appeared to be completely absent. These surprising results have spurred the field to question the true role of m Ca 2+ signaling in the normal and diseased heart.
To advance our understanding of m Ca 2+ uptake in the heart, in collaboration with the Molkentin lab, we generated a conditional, 
RESULTS

Generation of a Mcu Conditional Knockout Mouse Model and Validation of Functionality
The Mcu targeting construct was designed with loxP sites flanking the critical exons 5-6, which encode the DIME motif, an evolutionarily conserved sequence hypothesized to be necessary for Ca 2+ transport (Bick et al., 2012; Kwong et al., 2015, this issue). Three independent mutant ES cell lines were confirmed and subjected to morula aggregation and subsequent embryos transplanted into pseudo-pregnant females. Two of the three mutant ES cell lines produced germline mutant mice, which were crossed with ROSA26-FLPe mice for removal of the FRTflanked neomycin cassette ( Figure 1A ). Cre-mediated deletion of exons 5-6 results in a frameshift and early termination of translation causing complete loss of MCU protein in all cells expressing Cre recombinase. Homozygous ''floxed'' mice (Mcu fl/fl ) were interbred, and mouse embryonic fibroblasts (MEFs) were isolated from E13.5 embryos. MEFs were infected with adenovirus expressing Cre recombinase (Ad-Cre) or bgal control virus and cells were lysed for western blot analysis of MCU protein expression 6 days later. Ad-Cre treatment resulted in a dose-dependent loss of MCU ( Figure 1B ). COXIV was used as a mitochondrial loading control. (Expression of additional m Ca 2+ exchange associated proteins can be seen in ( Figure S1A ). ETC complex expression served as a mito loading control ( Figure S1B ). Figure 1C ). This difference was not attributable to a decrease in the i Ca 2+ transient ( Figure S1C ). Quantification of mitycam amplitude immediately following ATP treatment found an $75% decrease in m Ca 2+ ( Figure 1D ). Figure 2B ) (Oka et al., 2006) . No expression changes in ETC complex subunits were found ( Figure S2A ). To examine baseline m Ca 2+ content, ACMs were loaded with the ratiometric Ca 2+ reporter, Fura-2, and treated with Ru360 (MCU inhibitor), CGP37157 ( m NCX inhibitor), thapsigargin (SERCA inhibitor) and permeabilized with digitonin to block all Ca 2+ flux. During spectrofluorometric recording the protonophore, FCCP, was injected to dissipate Dc allowing the release of all matrix free-Ca 2+ ( Figure 2C ). Quantification of these data by calibration of the Fura-2 reporter in our experimental system ( Figure S2B ) found no change in matrix Ca 2+ content in Mcu knockout (KO) ACMs ( Figure 2D Figure 2I ). (H) JC-1-derived Dc prior to Ca 2+ additions.
(I) JC-1-derived Dc following seven pulses of 5 mM Ca 2+ .
All data shown as mean ± SEM, ***p<0.001 vs. bgal control.
To confirm that deletion of the Mcu gene results in loss of MCU channel activity (I MCU ), we isolated ACMs, generated mitoplasts, and employed the whole-mitoplast voltage-clamping technique developed by the Clapham group that first established the uniporter as the prototypical uptake channel (Kirichok et al., 2004) . I MCU was absent in Mcu-null mitoplasts subjected to a ramping protocol from À160 mV to 80 mV ( Figure 2J ). Quantitative analysis revealed a decrease in current density ( Figure 2K) , and likewise the current-time integral (area under the curve) was minimal ( Figure 2L ). These data are in agreement with initial and subsequent reports of MCU channel biophysical activity (Chaudhuri et al., 2013; Fieni et al., 2012; Kirichok et al., 2004 3C ). To corroborate this result, serum from the same cohort of mice was collected 24 hr after reperfusion, and a cardiac troponin-I (cTnI) ELISA was performed as a secondary marker of cardiomyocyte cell death. Mcu-deleted mice displayed an $65% reduction in cTnI versus controls ( Figure 3D ). We also examined DNA fragmentation by TUNEL staining, to demarcate cell death. We found a significant reduction in TUNEL + nuclei in the infarct boarder zone of Mcu cKO hearts as compared to controls ( Figures S3C and S3D ). Echocardiographic assessment of LV function 24 hr post-IR revealed a significant preservation of LV end-systolic diameter (LVESD) and percentage of fractional shortening (FS%) in Mcu knockout mice (Figures 3E-3G ). Additional M-mode echocardiographic data can be seen in Table S1 . To account for differences in regional wall motion due to variances in infarct size, we utilized speckle-tracking of B-mode echocardiographic recordings and likewise found an improvement in LV function in Mcu cKO mice post-IR (Figures S3E-S3I ).
To further examine the resistance of Mcu-null cardiomyocytes to mitochondrial depolarization during Ca 2+ overload as reported above in Figure 2I , we next isolated mitochondria from hearts and employed the classical mitochondrial-swelling assay to examine MPTP opening. Mitochondria isolated from Mcu-KO hearts failed to swell in response to increasing bath Ca 2+ , signified by a decrease in absorbance, in striking contrast to control mitochondria ( Figure 3H , red versus black line). For these experiments, we utilized a substantial Ca 2+ bolus (500 mM), such that the CypD inhibitor cyclosporine A (CsA) only had a partial inhibitory effect on swelling (gray line) in comparison to Mcu deletion. These data are quantified in Figure 3I as percentage of change in area under the curve versus control. It has previously been reported that MPTP opening occurs independent of CypD at high Ca 2+ loads similar to those utilized here (Baines et al., 2005) . To account for possible compensatory alterations in the expression of MPTP components, we immunoblotted for CypD, ANT, and VDAC ( Figure S3J ). We found no differences in expression between Mcu cKO and control hearts. These results support the hypothesis that the loss of Mcu prevents Ca 2+ from entering the matrix and activating the MPTP and thereby reduces IR-mediated cardiomyocyte cell death.
m Ca 2+ Uptake Is Necessary to Match Energetic Supply with b-Adrenergic Contractile Demand Numerous studies have suggested that ECC Ca 2+ cycling is integrated into mitochondria to match ATP production with workload (Williams et al., 2015) . Given that we did not find a significant difference in baseline cardiac function or resting m Ca 2+ and Mcu cKO mice were injected i.p. for 5 consecutive days with 40 mg/kg tamoxifen, and 10 days later we measured LV hemodynamic parameters during intravenous (i.v.) infusion of isoproterenol (Iso) ( Figure 4A ). Mcu cKO mice failed to increase LV contractility (dp/dt max) in response to b-adrenergic stimulation as compared to control mice ( Figure 4B ). In addition, there was a noted, although less dramatic, impairment in LV relaxation (dp/dt min, Figure 4C ). There was no significant difference in heart rate (HR) between groups over the course of Iso infusion ( Figure 4D ). Following 10 min of Iso infusion, we snap-froze ventricular tissue for metabolic analysis. We first evaluated the status of the pyruvate dehydrogenase complex (PDH), the prototypical m Ca 2+ -dependent enzyme that converts pyruvate into acetylCoA for use in the tricarboxylic acid (TCA) cycle. PDH is a central component linking glycolysis to OxPhos and also a contributor to the NADH pool. m Ca 2+ is reported to increase PDH phosphatase activity (PDP1), which, in turn, dephosphorylates the S293 residue on the E1 subunit resulting in increased PDH enzymatic activity. There was no change in the baseline expression of phospho-PDH, total PDH complex ( Figure 4E ), or other proposed m Ca 2+ -regulated dehydrogenases (a-ketoglutarate dehydrogenase and isocitrate dehydrogenase; Figure S4A ). However, expression analysis of post-Iso samples revealed a substantial decrease in phosphorylation of S293-E1 in control hearts versus Mcu cKO samples ( Figure 4F, top panel) . There was no change in total protein expression for any of the PDH subunits post-Iso ( Figure 4F, bottom panel) . Quantification of phospho/total E1-PDH revealed Mcu-KO hearts to have greater than a 3-fold difference in phosphorylation versus controls, signifying a failure to activate PDH during adrenergic stimulation ( Figure 4G ). This result was confirmed by our observation of an $50% decrease in Iso-stimulated PDH enzymatic activity in Mcu cKO hearts (Figures 4H and S4B ). To examine baseline energetics in more detail and rule out any compensatory changes in our Mcu cKO model, we employed metabolomics to measure the levels of several prominent TCA intermediates ( Figures S4C and S4D ). Mass spectrometry of ventricular tissue found no difference in any of the metabolites assayed.
Next, we measured the NAD + /NADH ratio, and, while we found no difference at baseline, acute Iso stimulation revealed an $2-fold difference in Mcu cKO hearts versus controls ( Figure 4I ). We also examined the NADP + /NADPH ratio and again found no difference at baseline but did find a trend of increased NADP + /NADPH ratio in Mcu cKO hearts during Iso infusion ( Figure S4E ). This was somewhat surprising since we thought NADPH generation was primarily extra-mitochondrial via the pentose phosphate pathway. However, mitochondrial enzymes such as malic enzyme, NADP-linked isocitrate dehydrogenase, and mitochondrial methylenetetrahydrofolate dehydrogenase are other significant sources of NADPH production (Fan et al., 2014; Huang and Colman, 2005; Palmieri et al., 2015; Yang et al., 1996) . It is intriguing to think that this may be another metabolic consequence of altering the m Ca 2+ microdomain during stress, be it direct or indirect modulation.
To further examine the hypothesis that MCU-Ca 2+ uptake is necessary to increase myocardial energy production in response to acute sympathetic signaling, we employed a cellular system to monitor energetic changes in real-time. ACMs were isolated (A) Mice in all groups received tamoxifen (40 mg/kg/ day) for 5 days and 1 week later were subjected to an isoproterenol (Iso) infusion protocol (0.1-10 ng/ml) over 15 min. (B-D) Invasive hemodynamic analysis of dp/dt max , dp/dt min , and heart rate (HR) during Iso infusion (minimum n = 7/group). (E) Baseline expression analysis of pyruvate dehydrogenase (PDH) phosphorylation at S293 of the E 1 a subunit and total PDH expression (subunits E2, E3bp, E 1 a, E1b). ETC Complex V-subunit d was used as a loading control. (F) Hearts were freeze-clamped at the conclusion of Iso infusion protocol and western blot examination of PDH phosphorylation at S293 of the E 1 a subunit, and total PDH expression (subunits E2, E3bp, E 1 a, E1b) was performed. Next, ACMs were monitored for changes in NADH autofluorescence intensity ( Figure 5A ). While we found no difference in basal NADH levels between groups ( Figure 5B ), the administration of Iso (10 mM) elicited a significant increase in NADH production in control ACMs, while Mcu-KO myocytes were unresponsive with NADH consumption being greater than production. Quantification of these data with correction to control ACMs can be seen in Figure 5C . To examine maximal NADH production in the presence of Iso, we next inhibited complex I of the ETC (NADH dehydrogenase) with rotenone. Mcu-KO ACMs displayed an $50% reduction in maximal NADH production, as compared to control ( Figure 5D ). To evaluate whether the lack of NADH responsiveness correlated with an alteration in OxPhos capacity, we measured ACM oxygen consumption rates (OCR) using a Seahorse extracellular flux analyzer. Corroborating our previous data showing no change in baseline NADH, there was no difference in baseline respiration between groups ( Figure 5E ). Next, we examined maximal respiratory capacity ( max OCR, 
FCCP treatment) in the presence of Iso or vehicle (veh). Mcu-null
ACMs displayed a significant reduction in max OCR, as compared to controls, and were completely refractory to Iso-mediated increases in mitochondrial respiration (Figure 5F ). In summation, these results support the concept of metabolic failure due to an inability to increase reducing equivalents during acute stress.
DISCUSSION
Since the 1970s, it has been apparent that mitochondria contained a protein capable of inducing an inward rectifying Ca 2+ current (Sottocasa et al., 1972) . The subsequent identification of a pharmacological inhibitor, of the channel, ruthenium red (RR), allowed investigators to begin to probe the cellular function of m Ca 2+ exchange (Moore, 1971 (Rasola and Bernardi, 2011) . Moreover, studies have shown that MPTP inhibition is potently cytoprotective, particularly in I/R injury, including a clinical trial evaluating the efficacy of cyclosporine-A (MPTP inhibitor) administration during reperfusion of the ischemic myocardium (Elrod and Molkentin, 2013; Piot et al., 2008) . It is likely that MPTP inhibition was not the sole protective mechanism, as decreasing m Ca 2+ load is also associated with decreased reactive oxygen species (ROS) generation during stress. Supporting this concept, we found a significant decrease in mitochondrial superoxide levels in Mcu-null cells following hypoxia/reoxygenation ( Figures S1D and S1E) . However, our IR injury results are contradictory to those recently reported by Pan et al. (2013) . Disparities in methodology likely account for the different results observed here. The previous study used a gene-trap approach with germline gene inactivation, versus our conditional, cardiomyocyte-specific deletion in the adult mouse. Therefore, compensatory pathways, induced by the loss of Mcu during development, may have allowed for the entry of Ca 2+ into the matrix in sufficient quantity, independent of MCU, to activate mitochondrial-dependent death pathways or alternatively mitochondrial-independent cell-death pathways may be upregulated in this mouse. (Figure S1C ). Yet another possible reason is the disparity in ischemic models. The Pan et al. study employed an ex vivo Langendorff global hypoxia model compared to our in vivo LCA ligation IR model. There are major differences between these methodologies, and, while unlikely, perhaps the ex vivo model somehow lessens the contribution of MCU-dependent Ca 2+ uptake in cardiomyocyte death. Our data do fit with previous reports of ruthenium red derivatives (MCU inhibitors) providing protection against IR injury (Zhang et al., 2006; Zhao et al., 2013 Figure S2C where, in control cells after permeabilization and addition of thapsigargin, we see a decrease in the Fura ratio prior to FCCP treatment signifying m Ca 2+ uptake, whereas in Mcudeleted cells we observe a rise in extra-mitochondrial Ca 2+ levels. The addition of the MCU inhibitor, Ru360, and m NCX inhibitor, CGP37157, prior to experimentation alleviated this problem. Summarizing the first part of our study, in a clinically relevant model of IR injury, we provide evidence that Mcu-mediated Ca 2+ uptake is a significant mechanism driving MPTP-mediated cardiomyocyte cell death and cardiac dysfunction. Further, we hypothesize that the m Ca 2+ exchange system possess a great deal of plasticity and that alternative uptake mechanisms maintain matrix Ca 2+ content during homeostasis. A more detailed examination of this phenomenon in future studies may aid the discovery of novel exchangers and pathways that account for the observed ''slow m Ca 2+ uptake.''
The heart is an aerobic organ that must constantly match energy supply with demand. The contractile function of the normal heart changes significantly during normal activities. This has led to the theory that i Ca 2+ cycling is integrated with mitochondria on a beat-to-beat basis to match ATP production with contractile demand as a real-time regulator of oxidative metabolism (Glancy and Balaban, 2012) . However, our current findings suggest that rapid MCU-dependent Ca 2+ uptake is dispensable for homeostatic cardiac function, as ablating Mcu had little effect on baseline function for all measured indices, including little to no change in LV function, structure, and cellular energetics. We found cardiomyocyte resting m Ca 2+ content to be $200 nM, and we did not detect appreciable mitochondrial uptake until concentrations of $8 mM were reached (control ACMs displayed only $17% uptake in response to a 10-mM-Ca 2+ load). Both of these values fit nicely within the range of previous studies examining cardiac MCU function that were recently summarized in eloquent fashion by Williams et al. (2013) . These data also agree with recent work proposing MICU1 binds MCU to inhibit uptake until a given threshold or set point of Ca 2+ is overcome (Csordá s et al., 2013; Mallilankaraman et al., 2012) . Since it is assumed global ECC i Ca 2+ cycling does not reach such levels in the homeostatic beating heart, we hypothesize that a slow MCU-independent influx mechanism must account for homeostatic maintenance of matrix Ca 2+ , aided by balanced m NCX efflux rates. It should be noted that Ca 2+ levels of this magnitude might occur in discrete microdomains where a sub-population of mitochondria are tethered in close proximity to SR/T-tubule junctions (Chen et al., 2012) . There are a number of mechanisms that theoretically could contribute to a slow MCU-independent m Ca 2+ uptake including: mito RyR, LETM1 (H + /Ca 2+ exchanger), reverse-mode m NCX, or an as of yet unknown exchanger(s) (Beutner et al., 2001; Jiang et al., 2009; Palty et al., 2010) . Additional evidence supporting MCU-independent uptake can be seen in a recent biophysical report describing a second ''RR-insensitive'' voltage-dependent inward rectifying current (Michels et al., 2009) . We hope that our future experiments will aid the identification of this MCU-independent uptake mechanism. While our data do not support a significant role for the MCU in basal cardiac physiology, cardiomyocyte-specific deletion did result in a striking inability to increase contractile function in response to the classic b-agonist, isoproterenol. Since a study published by Howell and Duke in 1906 , it has been appreciated that Ca 2+ is required for the ''augmenting influence of the sympathetic upon the heart'' (Howell and Duke, 1906) . Our understanding has continued to evolve over the last century, and the various molecular mechanisms of how bAR signaling regulates changes in excitation-contraction coupling (ECC) have been defined (Bers, 2008) . Our data extend these pathways to include MCUdependent Ca 2+ uptake as a mechanism necessary to upregulate energetics to support increases in cardiac contractility during acute sympathetic stress. Catecholamine signaling as occurs with the fight-or-flight response, strenuous exercise, or in the failing heart, elicits a marked increase in i Ca 2+ levels. Specifically, isoproterenol has been shown to dramatically increase peak i Ca 2+ and SR Ca 2+ load/release to levels sufficiently beyond those we show here are required for MCU-dependent uptake (Curran et al., 2007) . This large increase in i Ca 2+ is integrated into mitochondria to directly impact cellular energetics at multiple control points. m Ca 2+ increases the activity of three matrix dehydrogenases that are rate-limiting in the tricarboxylic (TCA) cycle (Denton, 2009 (Pan et al., 2013) . Similarly, our study found no change in baseline metabolic function or metabolite levels. However, our finding that HR was not altered in Mcu cKO mice does differ from a recent report by the Anderson group where they reported that an MCU-dominant-negative mouse model lacked chronotropic responsiveness to b-adrenergic stimulation (Wu et al., 2015) . This may be due to a difference in methodology, as we did not examine HR with implantable telemeters in conscious mice void of anesthesia. Overall, our model does support their hypothesis of MCU-mediated Ca 2+ entry playing a significant role in the cardiac fight-or-flight response. In summary, we show that the physiological function of MCUmediated Ca 2+ uptake in the heart is to augment mitochondrial energetic signaling to match ATP production with contractile demand during periods of acute adrenergic stress. In addition, our findings support a pathological role for MCU Ca 2+ influx driving mitochondrial depolarization and cell death during IR injury. While much work remains to fully elucidate all the molecular constituents of the MCU complex and their mechanistic function, our current study provides a fundamental framework to aid our understanding of m Ca 2+ uptake in health and disease.
EXPERIMENTAL PROCEDURES
Please see the Supplemental Information for detailed experimental procedures.
Generation of Mcu Conditional Knockout Mice
The gene targeting strategy in embryonic stem cells to generate the Mcu-loxP mice that we used here is described in Kwong et al. (2015) . In short, a Mcu conditional knockout mouse by recombinant insertion of a targeting gene construct containing loxP sites flanking exons 5-6 of the Mcu gene (ch10: 58930544-58911529) in mouse ES cells. Three independent mutant ES cell lines were confirmed and subjected to morula aggregation, and subsequent embryos were transplanted into pseudo-pregnant females. Two of the three mutant ES cell lines produced germline mutant mice, which were crossed with ROSA26-FLPe knockin mice for removal of the FRT-flanked neomycin cassette. 
Western Blot Analysis
All procedures were carried out as previously reported (Elrod et al., 2010) .
Isolation of ACMs
ACMs were isolated from ventricular tissue as described previously (Zhou et al., 2000) . All cells were used within 4 hr of isolation. . JC-1 (Enzo Life Sciences) was added to monitor Dc. Fluorescence signals for JC-1 and Fura were monitored on a PTI spectrofluorometer. All details are previously reported (Mallilankaraman et al., 2012) .
Mitochondria Isolation and Swelling Assay
Hearts were excised from mice and mitochondria were isolated as reported (Frezza et al., 2007) . For the swelling assay, mitochondria were diluted in assay buffer, and absorbance (abs) was recorded at 540 nm every 5 s. 500 mM CaCl 2 was injected to induce swelling ± 2 mM Cyclosporin A (CsA) (Elrod et al., 2010) .
ACM i Ca 2+ Transients
Isolated ACMs were loaded with Fluo-4 AM (Invitrogen) and placed in a 37 C heated chamber on an inverted microscope stage. ACMs were perfused with Tyrode's buffer and paced at 0.5 Hz. After baseline recordings, cells were perfused with Tyrode's containing 100 nM Iso. Ca 2+ transients were analyzed using Clampfit software.
Mitoplast Patch-Clamp Analysis of MCU Current
Following mitochondrial isolation, mitoplasts were prepared for patch-clamp studies. I MCU was recorded as previously described in detail (Kirichok et al., 2004) .
Metabolic Assays
Metabolomic analyses were carried out by metabolite profiling of ventricular tissue by LC-MS/MS as described (Jain et al., 2012) . NAD/NADH and NADP/NADPH ratios were quantified using luminescence assays (Promega). PDH activity was quantified using a fluorometric assay (Mitosciences).
In vitro experiments of ACM NADH production was monitored by recording autofluorescence using a spectrofluorometer. A XF96 extracellular flux analyzer (Seahorse Biosciences) was employed to measure OCR in isolated ACMs.
LV Echocardiography and Hemodynamics
Transthoracic echocardiography of the LV was performed and analyzed on a Vevo 2100 imaging system as previously reported (Elrod et al., 2007) . Invasive hemodynamic measurements in anesthetized mice was performed using a pressure catheter inserted into the right carotid artery and guided into the LV. Right jugular vein catheterization allowed delivery of Iso during recording.
Myocardial IR Injury LCA ligation and reperfusion was performed as previously described in Gao et al. (2010) . Infarct size was measured as previously reported (Elrod et al., 2007) . Serum was collected from mice after 24 hr R to measure cTnI using the Life Diagnostics ELISA kit. A TUNEL detection kit (Roche) was used to label DNA fragmentation in the infarct border zone of fixed heart sections.
MEF Isolation
Embryos were collected from Mcu fl/fl mice at E13.5 and MEFs isolated as previously reported (Baines et al., 2005) . MEFs were treated with Ad-Cre or Ad-bgal for 24 hr. 6-day post-infection cells were used for experiments. 
Hypoxia/Reoxygenation
MEFs were plated on 35-mm glass plates and, after culturing for 24 hr, loaded with 5 mM MitoSOX Red (Invitrogen). Cells were placed in ischemic medium for 1 hr, reoxygenated with Tyrode's buffer, and imaged 5 min later to evaluate mitochondrial superoxide production.
Statistics
All results are presented as mean ± SEM. Statistical analysis was performed using Prism 6.0 software (GraphPad). Where appropriate column analyses were performed using an unpaired, two-tailed t test (for two groups) or oneway ANOVA with Bonferroni correction (for groups of three or more 
